English
Home > Products > 402-67-5

China 402-67-5 Factory

We support our consumers with ideal high-quality goods and substantial level support. Becoming the specialist manufacturer in this sector, we now have acquired abundant practical encounter in producing and managing for 402-67-5,CAS NO 402-67-5,1-Fluoro-3-nitrobenzene, Please truly feel absolutely free to call us at any time. We will reply you when we receive your inquiries. Please note that samples are available before we start our company.
402-67-5, Our Company has specialist engineers and technical staff to answer your questions about maintenance problems, some common failure. Our product quality assurance, price concessions, any questions about the products, You should feel free to contact us.

Related Products

Hot Products

  • Betrixaban

    Betrixaban

    Product Name:Betrixaban
    Molecular Formula:C23H22ClN5O3
    Molecular Weight;451.91
    CAS Registry Number;330942-05-7
  • Tegoprazan

    Tegoprazan

    Product Name:Tegoprazan
    Molecular Formula:C20H19F2N3O3
    Molecular Weight;387.38
    CAS Registry Number;942195-55-3
  • CARCININE HYDROCHLORIDE

    CARCININE HYDROCHLORIDE

    Product Name:CARCININE HYDROCHLORIDE
    Molecular Formula:C8H14N4O
    Molecular Weight:182.22
    CAS Registry Number:56897-53-1
  • D(-)-Fructose

    D(-)-Fructose

    Product Name:D(-)-Fructose
    Molecular Formula:C6H12O6
    Molecular Weight:180.16
    CAS Registry Number:57-48-7
  • 1-(Tetrahydro-2H-pyran-4-yl)ethanone

    1-(Tetrahydro-2H-pyran-4-yl)ethanone

    Product Name:1-(Tetrahydro-2H-pyran-4-yl)ethanone
    Molecular Formula:C7H12O2
    Molecular Weight:128.17
    CAS Registry Number:137052-08-5
  • L-Alaninamide hydrochloride

    L-Alaninamide hydrochloride

    Product Name:L-Alaninamide hydrochloride
    Molecular Formula:C3H9ClN2O
    Molecular Weight:124.57
    CAS Registry Number:33208-99-0
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 402-67-5

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept